Type your search query and hit enter:
Home
Automobile
Entertainment
Esports
Food
Health
Life Style
News
Technology
Travel
Nasdaq:CRVS
Health
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am ET / 5:00 am PT…
3 hours ago